Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN   US0153511094

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/22/2014 07/23/2014 07/24/2014 07/25/2014 07/28/2014 Date
167.97(c) 173.08(c) 167.48(c) 167.04(c) 162.74(c) Last
1 588 628 1 753 224 2 882 576 1 176 719 1 632 114 Volume
+2.82% +3.04% -3.24% -0.26% -2.57% Change
More quotes
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders. It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
10/23Earnings Release
Surperformance© rating of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More about the company
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 2 197 M
EBIT 2014 1 091 M
Net income 2014 710 M
Finance 2014 1 770 M
Yield 2014 -
Sales 2015 2 686 M
EBIT 2015 1 342 M
Net income 2015 956 M
Finance 2015 2 912 M
Yield 2015 -
PER 2014 48,25
PER 2015 34,64
EV / Sales 2014 13,9x
EV / Sales 2015 10,9x
Capitalization 32 192 M
More Financials
Latest news on ALEXION PHARMACEUTICALS, I
1d ago NASDAQ 100 MOVERS : Mnst, dltr
4d ago ALEXION PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
5d ago ALEXION PHARMACEUTICALS : Results of Operations and Financial Condition, Financi..
5d ago ALEXION PHARMACEUTICALS : Assigned Patent
5d ago ALEXION PHARMACEUTICALS : Reports Second Quarter 2014 Results
5d ago ALEXION PHARMACEUTICALS : European Medicines Agency Accepts Marketing Authorizat..
7d ago NASDAQ 100 MOVERS : Nflx, wynn
07/16 ALEXION PHARMACEUTICALS : to Report Second Quarter 2014 Results on Thursday, Jul..
07/16 ALEXION PHARMACEUTICALS : Change in Directors or Principal Officers, Financial S..
07/16 ALEXION PHARMACEUTICALS : Announces the Appointments of David R. Brennan, M. Mic..
07/10 ALEXION PHARMACEUTICALS : to Report Second Quarter 2014 Results on Thursday, Jul..
07/09 S&P 500 MOVERS : Grmn, aa
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
Alexion Pharmaceuticals, I : Income Statement Evolution
More Financials
EPS Revisions
Alexion Pharmaceuticals, I : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF